BioAffinity Technologies (BIAF) stock rallied 55% after revealing CyPath Lung's potential to monitor lung cancer survivors for recurrence. Volume hit 17M shares. The post BioAffinity Technologies (BIAF) Stock Jumps 55% on CyPath Lung Cancer Survivor Monitoring News appeared first...